...
jnj-img

Johnson & Johnson, Common Stock

JNJ

NYQ

$146.62

+$0.38

(0.26%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$353.05B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
24.2119
Volume info-icon
This is the total number of shares traded during the most recent trading day.
7.72M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
3.38%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.52
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$139.79 L
$167.51 H
$146.62

About Johnson & Johnson, Common Stock

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameJNJSectorS&P500
1-Week Return-1.8%-2.27%-0.57%
1-Month Return-4.32%-3.96%1.21%
3-Month Return-11.42%-9.7%7.57%
6-Month Return0.8%-3.37%11.45%
1-Year Return-5.89%3.71%28.48%
3-Year Return-12.96%3.8%29.52%
5-Year Return3.71%39.78%90.66%
10-Year Return41.04%106.91%203.75%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue82.06B82.58B78.74B79.99B85.16B[{"date":"2019-12-31","value":96.36,"profit":true},{"date":"2020-12-31","value":96.98,"profit":true},{"date":"2021-12-31","value":92.46,"profit":true},{"date":"2022-12-31","value":93.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue27.56B28.43B23.40B24.60B26.74B[{"date":"2019-12-31","value":96.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":82.32,"profit":true},{"date":"2022-12-31","value":86.52,"profit":true},{"date":"2023-12-31","value":94.06,"profit":true}]
Gross Profit54.50B54.16B55.34B55.39B58.41B[{"date":"2019-12-31","value":93.31,"profit":true},{"date":"2020-12-31","value":92.71,"profit":true},{"date":"2021-12-31","value":94.74,"profit":true},{"date":"2022-12-31","value":94.83,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin66.42%65.58%70.28%69.25%68.59%[{"date":"2019-12-31","value":94.51,"profit":true},{"date":"2020-12-31","value":93.31,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.54,"profit":true},{"date":"2023-12-31","value":97.6,"profit":true}]
Operating Expenses33.53B34.42B34.40B33.18B36.56B[{"date":"2019-12-31","value":91.72,"profit":true},{"date":"2020-12-31","value":94.16,"profit":true},{"date":"2021-12-31","value":94.08,"profit":true},{"date":"2022-12-31","value":90.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income21.01B16.95B20.47B23.19B21.85B[{"date":"2019-12-31","value":90.58,"profit":true},{"date":"2020-12-31","value":73.06,"profit":true},{"date":"2021-12-31","value":88.26,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.22,"profit":true}]
Total Non-Operating Income/Expense(3.64B)(3.33B)(1.90B)(2.64B)(6.30B)[{"date":"2019-12-31","value":-364200000000,"profit":false},{"date":"2020-12-31","value":-332600000000,"profit":false},{"date":"2021-12-31","value":-189500000000,"profit":false},{"date":"2022-12-31","value":-264000000000,"profit":false},{"date":"2023-12-31","value":-630200000000,"profit":false}]
Pre-Tax Income17.33B16.50B19.18B19.36B15.06B[{"date":"2019-12-31","value":89.51,"profit":true},{"date":"2020-12-31","value":85.22,"profit":true},{"date":"2021-12-31","value":99.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":77.8,"profit":true}]
Income Taxes2.21B1.78B1.38B2.99B1.74B[{"date":"2019-12-31","value":73.9,"profit":true},{"date":"2020-12-31","value":59.65,"profit":true},{"date":"2021-12-31","value":46.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":58.08,"profit":true}]
Income After Taxes15.12B14.71B17.80B16.37B13.33B[{"date":"2019-12-31","value":84.93,"profit":true},{"date":"2020-12-31","value":82.66,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.96,"profit":true},{"date":"2023-12-31","value":74.86,"profit":true}]
Income From Continuous Operations15.12B14.71B17.80B16.37B13.33B[{"date":"2019-12-31","value":84.93,"profit":true},{"date":"2020-12-31","value":82.66,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.96,"profit":true},{"date":"2023-12-31","value":74.86,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income15.12B14.71B20.88B17.94B35.15B[{"date":"2019-12-31","value":43.01,"profit":true},{"date":"2020-12-31","value":41.86,"profit":true},{"date":"2021-12-31","value":59.39,"profit":true},{"date":"2022-12-31","value":51.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)8.688.039.8010.1610.43[{"date":"2019-12-31","value":83.22,"profit":true},{"date":"2020-12-31","value":76.99,"profit":true},{"date":"2021-12-31","value":93.96,"profit":true},{"date":"2022-12-31","value":97.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

JNJ
Cash Ratio 0.39
Current Ratio 1.03
Quick Ratio 0.79

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

JNJ
ROA (LTM) 8.40%
ROE (LTM) 20.89%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

JNJ
Debt Ratio Lower is generally better. Negative is bad. 0.61
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.39

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

JNJ
Trailing PE 24.15
Forward PE 13.79
P/S (TTM) 4.03
P/B 5.03
Price/FCF 62
EV/R 4.20
EV/Ebitda 14.35
PEG 0.87

FAQs

What is Johnson & Johnson share price today?

Johnson & Johnson (JNJ) share price today is $146.62

Can Indians buy Johnson & Johnson shares?

Yes, Indians can buy shares of Johnson & Johnson (JNJ) on Vested. To buy Johnson & Johnson from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in JNJ stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Johnson & Johnson be purchased?

Yes, you can purchase fractional shares of Johnson & Johnson (JNJ) via the Vested app. You can start investing in Johnson & Johnson (JNJ) with a minimum investment of $1.

How to invest in Johnson & Johnson shares from India?

You can invest in shares of Johnson & Johnson (JNJ) via Vested in three simple steps:

  • Click on Sign Up or Invest in JNJ stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Johnson & Johnson shares
What is Johnson & Johnson 52-week high and low stock price?

The 52-week high price of Johnson & Johnson (JNJ) is $167.51. The 52-week low price of Johnson & Johnson (JNJ) is $139.79.

What is Johnson & Johnson price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Johnson & Johnson (JNJ) is 24.2119

What is Johnson & Johnson price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Johnson & Johnson (JNJ) is 5.03

What is Johnson & Johnson dividend yield?

The dividend yield of Johnson & Johnson (JNJ) is 3.38%

What is the Market Cap of Johnson & Johnson?

The market capitalization of Johnson & Johnson (JNJ) is $353.05B

What is Johnson & Johnson’s stock symbol?

The stock symbol (or ticker) of Johnson & Johnson is JNJ

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top